- Three new Takeda diabetes drugs become available
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
- Pain Relief 2013
- FDA to allow dispensing of GSK's Type 2 diabetes drug Avandia in retail pharmacies again
HYDERABAD, India — The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.
Aurobindo announced the approval of pioglitazone tablets in the 15 mg, 30 mg and 45 mg strengths, in addition to the earlier tentative approval it received for pioglitazone and metformin hydrochloride tablets in the 15 mg/500 mg and 15 mg/850 mg strengths.
Pioglitazone tablets are a generic version of Takeda's Actos, while pioglitazone and metformin hydrochloride tablets are a generic version of Takeda's Actoplus Met. The products had combined sales of $2.8 billion in the 12-month period ending in September 2012, according to IMS Health.